Are you Dr. Lowery?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 E 66th St
New York, NY 10065Phone+1 646-888-4543
Summary
- Dr. Maeve Lowery, MD is an oncologist in New York, New York. She is currently licensed to practice medicine in New York. She is affiliated with Memorial Sloan Kettering Cancer Center and is an Instructor at Weill Cornell Medical College.
Education & Training
University College of Dublin National Univ SOMClass of 2003
Certifications & Licensure
NY State Medical License 2011 - 2019
Clinical Trials
- First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma Start of enrollment: 2013 Apr 01
- Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer Start of enrollment: 2014 Nov 17
Publications & Presentations
PubMed
- 510 citationsIvosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K. Abou-Alfa, Teresa Macarulla, Milind Javle, Robin Kate Kelley, Sam J. Lubner
The Lancet. Oncology. 2020-06-01 - 136 citationsSafety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 studyMaeve A. Lowery, Howard A. Burris, Filip Janku, Rachna T. Shroff, James M. Cleary
The Lancet. Gastroenterology & Hepatology. 2019-09-01 - 853 citationsMutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha
Nature Medicine. 2017-06-01
Authored Content
- Phase II Trial of Veliparib in Patients with Previously Treated BRCA-Mutated Pancreas Ductal Adenocarcinoma☆January 2018
Press Mentions
Trinity Lead Network of ‘The Best Minds in Ireland' Studying Oesophageal CancerFebruary 9th, 2023- Cancer Conference Zeros in on ResearchNovember 11th, 2022
- Trinity Study Discovers Genetic Mutation Behind Incurable Childhood CancerJuly 22nd, 2021
- Join now to see all
